Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose ...

The development saga for the depression molecule has been rocky for years, unable to ease symptoms in multiple late-stage ...

However, in 1995, antihypertensive drug visits that included a diuretic and/or a β-adrenergic blocker equalled 53%; these are the antihypertensive drug classes preferred by the JNC V. Physician ...